Oxydon 80 mg Prolonged-release tablets

Land: Irland

Sprog: engelsk

Kilde: HPRA (Health Products Regulatory Authority)

Aktiv bestanddel:

OXYCODONE HYDROCHLORIDE

Tilgængelig fra:

Rowex Ltd

ATC-kode:

N02AA; N02AA05

INN (International Name):

OXYCODONE HYDROCHLORIDE

Dosering:

80 milligram(s)

Lægemiddelform:

Prolonged-release tablet

Recept type:

Product subject to prescription which may not be renewed (A)

Terapeutisk område:

Natural opium alkaloids; oxycodone

Autorisation status:

Not marketed

Autorisation dato:

2007-12-19

Indlægsseddel

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT
OXYDON 20 MG PROLONGED-RELEASE TABLETS
OXYDON 40 MG PROLONGED-RELEASE TABLETS
OXYDON 80 MG PROLONGED-RELEASE TABLETS
oxycodone hydrochloride
_ _
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.
-
If you get any side effects , talk to your doctor or pharmacist. This
includes any possible side
effects not listed in this leaflet. See section 4.
_ _
WHAT IS IN THIS LEAFLET
1.
What Oxydon
is and what it is used for
2.
What you need to know before you take Oxydon
3.
How to take Oxydon
4.
Possible side effects
5.
How to store Oxydon
6.
Contents of the pack and other information
1.
WHAT OXYDON IS AND WHAT IT IS USED FOR
Oxydon contains the active substance oxycodone hydrochloride which is
a centrally acting, strong
painkiller of the group of opioids.
Oxydon is used in adults and adolescents aged 12 years and older to
treat severe pain, which can be
adequately managed only with opioid analgesics.
2.
WHAT YOU NEED TO KNOW BEFORE YOU TAKE OXYDON
DO NOT TAKE OXYDON IF YOU

are allergic to oxycodone hydrochloride or any of the other
ingredients of this medicine (listed in
section 6)

have breathing problems, such as severely depressed breathing
(respiratory depression), severe
chronic obstructive lung disease, or severe bronchial asthma. Symptoms
may include
breathlessness, coughing or breathing more slowly or weakly than
expected.

have elevated carbon dioxide blood levels

have a heart problem after long-term lung disease (cor pulmonale)

suffer from intestinal paralysis (paralytic ileus). Signs may be that
your stomach empties more
slowly than it should (delayed gastric emptying) or you have severe
pain in your abdomen.
WARN

Produktets egenskaber

Health Products Regulatory Authority
16 May 2022
CRN00CVPZ
Page 1 of 11
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Oxydon 80 mg Prolonged-release tablets
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each prolonged-release tablet contains 80 mg oxycodone hydrochloride
corresponding to 71.7 mg oxycodone.
Excipient(s) with known effect:
Each prolonged-release tablet contains a maximum of 23 mg sucrose.
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Prolonged-release tablet
Yellow, biconvex, oblong prolonged-release tablets with a breakline on
both sides.
The prolonged-release tablets can be divided into equal doses.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Severe pain, which can be adequately managed only with opioid
analgesics.
Oxydon prolonged-release tablets are indicated in adults and
adolescents aged 12 years and older.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Posology
The dose should be adjusted to the intensity of the pain and the
sensitivity of the individual patient.
For doses not practicable with this medicinal product other strengths
are available.
_Adults and adolescents (12 years of age and older)_
_Starting dose_
The usual starting dose for an opioid naïve patient is 10 mg
oxycodone hydrochloride per dose at intervals of 12 hours. Some
patients may benefit from a starting dose of 5 mg to minimise the
incidence of adverse reactions.
Patients already receiving opioids may start treatment with higher
doses of Oxydon taking into account their experience with
former opioid therapies.
10 to 13 mg oxycodone hydrochloride correspond to approximately 20 mg
of morphine sulphate, both in the
prolonged-release formulation.
_Dose adjustment_
Some patients who take Oxydon prolonged-release tablets following a
fixed schedule need rapid release analgesics as rescue
medication in order to control breakthrough pain. Oxydonis not
intended for therapy of breakthrough pain. The single dose of
the rescue medication should amount to 1/6 of the equianalgesic daily
dos